The Human Papillomavirus Type 16 E6 Oncoprotein Can Down-Regulate p53 Activity by Targeting the Transcriptional Coactivator CBP/p300

Tekijä Zimmermann, Holger, Degenkolbe, Roland, Bernard, Hans-Ulrich, O’Connor, Mark J.
Julkaistu 1999

Suppression of retroviral infection by the RAD52 DNA repair protein

Tekijä Lau, Alan, Kanaar, Roland, Jackson, Stephen P, O'Connor, Mark J
Julkaistu 2004

Characterization of an E1A-CBP Interaction Defines a Novel Transcriptional Adapter Motif (TRAM) in CBP/p300

Tekijä O’Connor, Mark J., Zimmermann, Holger, Nielsen, Søren, Bernard, Hans-Ulrich, Kouzarides, Tony
Julkaistu 1999

Activated germinal center B cells undergo directed migration

Tekijä O’Connor, Mark J., Hauser, Anja E., Haberman, Ann M., Kleinstein, Steven H.
Julkaisussa Int J Data Min Bioinform (2011)

A Novel YY1-Independent Silencer Represses the Activity of the Human Papillomavirus Type 16 Enhancer

Tekijä O’Connor, Mark J., Stünkel, Walter, Zimmermann, Holger, Koh, Choon-Heng, Bernard, Hans-Ulrich
Julkaistu 1998

The Differentiation-Specific Factor CDP/Cut Represses Transcription and Replication of Human Papillomaviruses through a Conserved Silencing Element

Tekijä O'Connor, Mark J., Stünkel, Walter, Koh, Choon-Heng, Zimmermann, Holger, Bernard, Hans-Ulrich
Julkaistu 2000

Nuclear Matrix Attachment Regions of Human Papillomavirus Type 16 Repress or Activate the E6 Promoter, Depending on the Physical State of the Viral DNA

Tekijä Stünkel, Walter, Huang, Zhonghui, Tan, Shyh-Han, O'Connor, Mark J., Bernard, Hans-Ulrich
Julkaistu 2000

Sensitivity to Poly(ADP-ribose) Polymerase (PARP) Inhibition Identifies Ubiquitin-specific Peptidase 11 (USP11) as a Regulator of DNA Double-strand Break Repair

Tekijä Wiltshire, Timothy D., Lovejoy, Courtney A., Wang, Tong, Xia, Fen, O'Connor, Mark J., Cortez, David
Julkaistu 2010

ATR kinase inhibition induces unscheduled origin firing through a Cdc7-dependent association between GINS and And-1

Tekijä Moiseeva, Tatiana, Hood, Brian, Schamus, Sandy, O’Connor, Mark J., Conrads, Thomas P., Bakkenist, Christopher J.
Julkaisussa Nat Commun (2017)

The orally active and bioavailable ATR kinase inhibitor AZD6738 potentiates the anti-tumor effects of cisplatin to resolve ATM-deficient non-small cell lung cancer in vivo

Tekijä Vendetti, Frank P., Lau, Alan, Schamus, Sandra, Conrads, Thomas P., O'Connor, Mark J., Bakkenist, Christopher J.
Julkaisussa Oncotarget (2015)

Dynamic inhibition of ATM kinase provides a strategy for glioblastoma multiforme radiosensitization and growth control

Tekijä Golding, Sarah E, Rosenberg, Elizabeth, Adams, Bret R, Wignarajah, Shayalini, Beckta, Jason M, O'Connor, Mark J, Valerie, Kristoffer
Julkaistu 2012

ATM-deficiency sensitizes Mantle Cell Lymphoma cells to PARP-1 inhibitors

Tekijä Williamson, Chris T., Muzik, Huong, Turhan, Ali G., Zamò, Alberto, O’Connor, Mark J., Bebb, D. Gwyn, Lees-Miller, Susan P.
Julkaistu 2010

Differential therapeutic effects of PARP and ATR inhibition combined with radiotherapy in the treatment of subcutaneous versus orthotopic lung tumour models

Tekijä Tran Chau, Vanessa, Liu, Winchygn, Gerbé de Thoré, Marine, Meziani, Lydia, Mondini, Michele, O’Connor, Mark J., Deutsch, Eric, Clémenson, Céline
Julkaisussa Br J Cancer (2020)

Identifying and Overcoming Mechanisms of PARP Inhibitor Resistance in Homologous Recombination Repair-Deficient and Repair-Proficient High Grade Serous Ovarian Cancer Cells

Tekijä Gomez, Miriam K., Illuzzi, Giuditta, Colomer, Carlota, Churchman, Michael, Hollis, Robert L., O’Connor, Mark J., Gourley, Charlie, Leo, Elisabetta, Melton, David W.
Julkaisussa Cancers (Basel) (2020)

Inhibition of poly(ADP-ribose) polymerase-1 by olaparib (AZD2281) increases the radiosensitivity of a lung tumor xenograft

Tekijä Senra, Joana M., Telfer, Brian A., Cherry, Kim E., McCrudden, Cian M., Hirst, David G., O’Connor, Mark J., Wedge, Stephen R., Stratford, Ian J.
Julkaistu 2011

Evaluation of candidate biomarkers to predict cancer cell sensitivity or resistance to PARP-1 inhibitor treatment

Tekijä Oplustilova, Lenka, Wolanin, Kamila, Mistrik, Martin, Korinkova, Gabriela, Simkova, Dana, Bouchal, Jan, Lenobel, Rene, Bartkova, Jirina, Lau, Alan, O’Connor, Mark J., Lukas, Jiri, Bartek, Jiri
Julkaistu 2012

Correction to Oplustilova L, et al. Cell Cycle Volume 11, Issue 20; pp. 3837–50

Tekijä Oplustilova, Lenka, Wolanin, Kamila, Mistrik, Martin, Korinkova, Gabriela, Simkova, Dana, Bouchal, Jan, Lenobel, Rene, Bartkova, Jirina, Lau, Alan, O’Connor, Mark J., Lukas, Jiri, Bartek, Jiri
Julkaistu 2013

Neoadjuvant olaparib targets hypoxia to improve radioresponse in a homologous recombination-proficient breast cancer model

Tekijä Borst, Gerben R., Kumareswaran, Ramya, Yücel, Hatice, Telli, Seyda, Do, Trevor, McKee, Trevor, Zafarana, Gaetano, Jonkers, Jos, Verheij, Marcel, O’Connor, Mark J., Rottenberg, Sven, Bristow, Robert G.
Julkaisussa Oncotarget (2017)

Correction: Neoadjuvant olaparib targets hypoxia to improve radioresponse in a homologous recombination-proficient breast cancer model

Tekijä Borst, Gerben R., Kumareswaran, Ramya, Yücel, Hatice, Telli, Seyda, Do, Trevor, McKee, Trevor, Zafarana, Gaetano, Jonkers, Jos, Verheij, Marcel, O’Connor, Mark J., Rottenberg, Sven, Bristow, Robert G.
Julkaisussa Oncotarget (2020)

Investigation of Radiosensitivity Gene Signatures in Cancer Cell Lines

Tekijä Hall, John S., Iype, Rohan, Senra, Joana, Taylor, Janet, Armenoult, Lucile, Oguejiofor, Kenneth, Li, Yaoyong, Stratford, Ian, Stern, Peter L., O’Connor, Mark J., Miller, Crispin J., West, Catharine M. L.
Julkaistu 2014